Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show

Thermo Fisher's Greenville, N.C. plant has been found in breach of US FDA regulations, including twice this year
FDA's most recent inspection of Thermo Fisher plant found shortfalls in manufacturing of Sanofi's and AstraZeneca's Beyfortus RSV treatment
Sanofi says the FDA findings were addressed and all Beyfortus doses were approved by FDA before they were shipped